Cisplatin (CP) is a broad-spectrum antineoplastic agent, used to treat many different types of
malignancies due to its high efficacy and low cost. However, its use is largely limited by …

While long‐term survivors (5 years+) do not face the stressors of diagnosis and treatment,
they continue to face the uncertainties that survivorship brings: recurrence, other cancers …

Despite significant improvement in cancer survival, the fear of death still remains rooted in
individuals' beliefs about cancer. Existential fears pertaining to cancer cut across the cancer …

This chapter addresses the confluence of two sets of processes—stress and co**—as
they come to bear on health. It first addresses the following questions: What defines the …

Background: While much is now known about breast cancer survivors' long‐term health,
quality of life, and psychological state, relatively little is known about the period immediately …

Background: Fear of recurrence (FOR) has been increasingly recognised as an issue of
significant burden for most cancer patients, and has been associated with psychological …

This research focuses on the co** behavior of older adult, long‐term cancer survivors.
Specifically, it identifies the personal (including race and gender) and illness/treatment …

Abstract Background: Active for Life After Cancer is a randomized trial evaluating the efficacy
of a 6‐month group‐based lifestyle physical activity program (Lifestyle) for prostate cancer …

Background Information about the nature of public reactions to people with Alzheimer's
disease (AD) can help reduce stigmatization associated with the disease. Objective The aim …

Objectives Adjuvant endocrine therapy for early‐stage breast cancer has greatly reduced
the morbidity and mortality associated with breast cancer recurrence. Despite this, a …